Long noncoding RNA, CCDC26, controls myeloid leukemia cell growth through regulation of KIT expression

Abstract

BackgroundAccumulating evidence suggests that some long noncoding RNAs (lncRNAs) are involved in certain diseases, such as cancer. The lncRNA, CCDC26, is related to childhood acute myeloid leukemia (AML) because its copy number is altered in AML patients.ResultsWe found that CCDC26 transcripts were abundant in the nuclear fraction of K562 human myeloid leukemia cells. To examine the function of CCDC26, gene knockdown (KD) was performed using short hairpin RNAs (shRNAs), and four KD clones, in which CCDC26 expression was suppressed to 1% of its normal level, were isolated. This down-regulation included suppression of CCDC26 intron-containing transcripts (the CCDC26 precursor mRNA), indicating that transcriptional gene suppression (TGS), not post-transcriptional suppression, was occurring. The shRNA targeting one of the two CCDC26 splice variants also suppressed the other splice variant, which is further evidence for TGS. Growth rates of KD clones were reduced compared with non-KD control cells in media containing normal or high serum concentrations. In contrast, enhanced growth rates in media containing much lower serum concentrations and increased survival periods after serum withdrawal were observed for KD clones. DNA microarray and quantitative polymerase chain reaction screening for differentially expressed genes between KD clones and non-KD control cells revealed significant up-regulation of the tyrosine kinase receptor, KIT, hyperactive mutations of which are often found in AML. Treatment of KD clones with ISCK03, a KIT-specific inhibitor, eliminated the increased survival of KD clones in the absence of serum.ConclusionsWe suggest that CCDC26 controls growth of myeloid leukemia cells through regulation of KIT expression. A KIT inhibitor might be an effective treatment against the forms of AML in which CCDC26 is altered.Electronic supplementary materialThe online version of this article (doi:10.1186/s12943-015-0364-7) contains supplementary material, which is available to authorized users.

Genome-Wide Association and Replication Study of Hepatotoxicity Induced by Antiretrovirals Alone or with Concomitant Anti-Tuberculosis Drugs

“…In fact, recently, hepatic lncRNAs are reported to be involved in the progression of liver fibrosis (He et al, 2014;Yu et al, 2016;Zheng et al, 2015). Previous GWAS studies revealed some SNPs within the lincRNAs as disease associated (Hirano et al, 2015;Radtke et al, 2009).…”

A 4-lncRNA scoring system for prognostication of adult myelodysplastic syndromes

“…As lncRNAs have emerged as important participants in the pathogenesis and disease progression of AML, [66][67][68][69][70][71][72][73][74] it is likely that profiling of their expression would have significant impact on MDS prognostication. Recently, it has been shown that lncRNA expression signatures were closely associated with specific mutations and a small subset of lncRNAs could predict clinical outcome in cytogenetically normal elderly AML patients, 75 but the clinical significance of lncRNA profiling in MDSs has not yet been reported.…”

Long non‑coding RNA PAX8‑AS1 polymorphisms increase the risk of childhood acute lymphoblastic leukemia

“…LncRNAs have tissue-specific expression and serve an important role in the human transcriptome by regulating normal tissue differentiation as well as cancer development (30). Notably, a number of previous studies have implicated a role of lncRNA dysregulation, of transcripts including leukemia-induced non-coding activator RNA, B-ALL-associated long RNA (BALR)-6 and -2, NOTCH1-associated lncRNA in T-ALL and CCDC26, in tumorigenicity in leukemias (31)(32)(33)(34). SNPs may significantly influence gene expression and function.…”